Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Shuttle Pharmaceuticals Holdings will go public soon, but the exact IPO date is still unknown.
Stock Price: $4.50 - $5.00
Current IPO price range
Chart not available yet
Data will show when the stock starts trading.
| Market Cap | 63.29M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -1.81M |
| Shares Out | 13.32M |
| EPS (ttm) | -0.14 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About SHPH
Shuttle Pharmaceuticals is a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT). Although RT is a proven modality for treating cancers, by developing radiation sensitizers, we aim to increase cancer cure rates, prolong patient survival and improve quality of life when used as a primary treatment, or in combination with surgery, chemotherapy and immunotherapy. We currently have no FDA approved products and we have not yet applied for a new drug... [Read more...]
Industry
Health Care
Founded
2012
CEO
Anatoly Dritschilo, M.D.
Employees
5
Stock Exchange
NASDAQ
Ticker Symbol
SHPH
Financial Performance
Financial StatementsNews
Shuttle Pharmaceuticals Holdings IPO Registration Document (S-1)
Shuttle Pharmaceuticals Holdings has filed to go public with an IPO on the NASDAQ